Microbio is an Australian biotechnology startup that aims to revolutionise pathogen detection with our unique, specific, sensitive and fast pathogen identification test. Our novel diagnostic method combines the latest advances in bioinformatics, genomics and molecular microbiology.
MinterEllison provides legal and consulting services to a diverse client base across industries through offices in Australia and a global network of member firms and associated companies. In Australia, MinterEllison is one of the country's largest law firms.
information to follow
Founded in the mid-1970s as a collective of scientists committed to developing innovative products for the life sciences industry, New England Biolabs is now a recognized world leader in the discovery and production of enzymes for molecular biology applications.
Founded in 2004 and publicly traded since 2010, Northwest (TSX: NWH.UN) is a global real estate investor and asset manager focused on properties and partnerships at the intersection of healthcare, knowledge, and research. We're a real estate investment trust with more than $10B of assets under management, owning and operating a portfolio of more than 230 high-quality properties across Canada, the United States, Brazil, Germany, the Netherlands, the United Kingdom, Australia, and New Zealand.
NuNerve Pty Ltd collaborates with scientists from the University of Queensland to develop a drug candidate for treating motor neurone disease (MND). The drug blocks the EphA4 protein, which plays a crucial role in motor neuron guidance and inhibiting their recovery after injury. This discovery has implications for MND, spinal cord injury, and other neurological diseases, offering a potential treatment for MND patients. NuNerve aims to manufacture the drug for upcoming clinical trials, prioritizing communication through healthcare professionals and providing updates via the QBI website and newsletter. Their urgent goal is to find a cure or disease-modifying strategy for MND.
NuPlant has developed advanced robotic systems for plant tissue-culture. Our SmartClone Sirius and Gemini systems support dissections every three seconds; they unprecedently allow dynamic media change. Our Janus transplanter transfers plantlets to soil and re-assembles consumables for washing in our Neptune system for sustainable re-use. These systems flexibly provide tougher plantlets in shorter time at lower cost.
Nucleus Network's Brisbane facility, formerly known as Q-Pharm, is a dedicated clinical trial unit situated at the Royal Brisbane and Women's Hospital. As Australia's second-largest Phase 1 unit, it conducts clinical trials for companies and researchers involved in developing new, safer, and more effective medications. With over 15 years of reliable experience, Q-Pharm has successfully completed over 400 Early Phase studies and recruited over 15,000 participants. Specializing in early-phase (phases 1 and 2) clinical trials, Q-Pharm operates in a cutting-edge facility located in the Herston precinct at the Royal Brisbane and Women's Hospital in Brisbane, Australia.
OneVentures are one of Australia’s leading venture capital firms, with over $650 million in funds under management and are now looking for new opportunities in the healthcare and technology sectors. We work with companies to take them to that all important next stage, by actively shaping their future. We apply our years of experience, expertise, operational and executional excellence to accelerate their growth and launch them into global markets.
Our Eco Bee’s provisionally-patented technology incorporates revolutionary beekeeping and agricultural eco-system inventions which seek to solve complex ecological, environmental and social problems to ensure: · Beekeepers are profitable and productive · Honey bees are flourishing · Food security is accessible · Agribusiness is sustainable To learn more, please contact Jen Wilks on 61 403 714 006 or via email jen@ourecoclean.com or visit our website.
PRAXIS Australia is leading national and international education and training provider of high-quality, relevant and accessible training to build the confidence and capability of those working in clinical trials, research and ethics. Their offers have been built upon Harvard Multi-Regional Trials Centre competencies and aligned to NHMRC competencies. These training offers are a benchmark for research and clinical trials professionals in Australia, New Zealand, Asia Pacific Region, Europe, and the United States.
PSC Biotech is a provider of life sciences essential services, ensuring the development, manufacturing, and distribution of medical and biotech products meet regulatory standards. The Australian team specializes in GMP Engineering, offering expertise in commissioning, qualification, and validation (CQV). They assist with validation project planning, documentation generation, execution, and summary reports. Additionally, PSC Biotech offers computer system validation (CSV) and technical writing support for operational readiness. Their focus is on maintaining compliance and delivering high-quality services in the life sciences industry.
Patheon Biologics, a division of Thermo Fisher Scientific, offers comprehensive pharmaceutical services to support the entire biotechnology and pharmaceutical life cycle. Thermo Fisher's pharma services solutions aid customers in accelerating innovation and enhancing productivity in drug development and commercialization. As a strategic contract development and manufacturing organization (CDMO) and clinical services partner, they serve the pharmaceutical, biotech, and life sciences industries. At their mammalian-based cGMP facility in Brisbane, Australia, Patheon supports clients in large-scale GMP manufacturing of biopharmaceuticals.
PharmaSols is the longest established, best connected, privately-owned Clinical Research Organisation (CRO) in the Pacific region. They have international experience with large pharmaceutical, medical device and biotech organisations, with expertise across a wide variety of therapeutic areas.
Protagonist Therapeutics is a clinical-stage biopharmaceutical company. We strive to improve patients’ lives through the power of peptide drug discovery and development, targeting areas of unmet need across rare and prevalent diseases where treatments are limited or inadequate.
QBiotics Group is dedicated to improving the lives of people and animals by discovering and creating transformational pharmaceuticals derived from nature. Our primary programmes are in oncology and wound healing.
QIMR Berghofer Medical Research Institute is a world- leading translational research institute where research develops from the laboratory bench to the patient’s bedside. With almost 900 scientists, students and support staff, and more than 50 state-of-the-art laboratories, QIMR Berghofer is one of Australia’s largest and most successful institutes.
The aims of the Centre for Genomics and Personalised Health are to translate knowledge from genomics research to improve human health, by discovering better methods of diagnosing disease, developing targeted treatments based on genetics, and training the next generation of translational genomics scientists.
Queensland University of Technology (QUT) is a renowned Australian university that emphasizes a global perspective. With nearly 50,000 students, QUT offers real-world infrastructure, education, and graduate skills to empower the next generation of change-makers. Collaborating with various universities, institutions, and hospitals, QUT is dedicated to research excellence. Their research team is highly regarded for providing government, businesses, and organizations with top-notch research resources. QUT houses cutting-edge facilities and research groups focused on innovative research across various health disciplines. QUT is home to the Centre for Genomics and Personalised Health, contributing to advancements in personalized medicine.
Established in 2003, the Queensland Brain Institute is a leading research institute focused on two of the greatest challenges of modern science: understanding brain function, and preventing and treating disorders of brain function.
QCIF (the Queensland Cyber Infrastructure Foundation) provides the high-performance services, infrastructure and support required to achieve excellence in computation and data-driven collaborative research and its application in industry. QCIF operates with its members and partners delivering services to research throughout Queensland and increasingly via Commonwealth programs to the nation.
The Queensland Emory Drug Discovery Initiative (QEDDI) is a unique small molecule drug discovery and development group operating within an Australian university, UniQuest. Their mission is to bridge the gap between academic biomedical research and the development of new medicines. With an industry-experienced team, QEDDI focuses on advancing biomedical research into promising drug candidates to facilitate commercial partnerships and expedite drug development. They possess core capabilities and expertise in medicinal chemistry, compound screening, and profiling, enabling them to drive the discovery of innovative therapeutics.
We are a global drug development accelerator with over 1,300 staff operating from state-of-the-art development, manufacturing and clinical testing facilities in the U.S. and U.K. We have over 30 years of experience and have worked on over 3,000 molecules across all stages of development.
Radium Capital is Australia’s market leader in advances of the R&D Tax Incentive refund. Since launching in 2017, we’ve helped hundreds of innovators build their businesses the strategic way.
Research Collective provides Development, implementation and management of research grant operations; Grants peer review and Change Management services in the health and medical research sector.
Resolian Bioanalytics is a leading global research laboratory providing services for the pharmaceutical, biotechnology, and medical device industries.
RSB works to ensure that the inevitable transformation to a biocircular economy is truly environmentally sustainable and socially just. In partnership with the RSB membership community, we have developed a robust and credible sustainability framework, also known as the RSB Principles & Criteria. The RSB Principles & Criteria describe how to ensure that this global transition is grounded in a holistic sustainability approach that goes beyond decarbonisation – advancing positive social and environmental outcomes.
Breathe Easy is our core philosophy and the force behind everything we do for you. We understand the last thing you want to worry about is the air you breathe and operate in each day. We manage your risk to ensure that you can Breathe Easy. We are an accredited company specialising in supporting semiconductor, pharmaceutical, healthcare and HVAC facilities to manage, maintain and certify critical assets and controlled environments. Our team are industry-leading experts who implicitly understand the risks you manage each day. It’s in our DNA. We hold ourselves accountable to the highest standards while completing various services for our clients. In addition to our ISO 17025 accreditation, we remain committed to industry partnerships and the sustainable environments we manage for clients across multiple sectors.
Sanofi Australia is part of a global healthcare organisation that employs over 100,000 people across 170 countries. Our purpose is to bring hope, relief and cures to patients with the medicines and vaccines that we make. Established in Australia in 1980, our heritage spans 100 years, pioneering medicine across broad therapeutic areas including diabetes, cardiovascular disease, influenza, oncology, immunology, rare diseases and rare blood disorders. Today in Australia we are a leading supplier of diabetes medicines and vaccines. We strive to provide quality vaccination coverage from infectious diseases to all Australians. 95% of young Australian’s will have had a Sanofi vaccine by age five, and one in four Australians has had one of our flu vaccines. Due to our global manufacturing network and dedicated local team of over 700 people, we reliably supply quality innovative vaccines, medicines and healthcare solutions, throughout the country, enabling those in rural and remote locations to access our treatments. Our breakthrough science, technology and unique collaborations allow us to accelerate access to scientific innovation and benefit the lives of patients who depend on us. From the many with rare conditions, the millions with chronic disease to those seeking protection from infectious disease. In collaboration with clinicians, our clinical trials are an important phase of our research, and annually supports access for over 500 Australians to many scientific innovations including those for atopic dermatitis, multiple sclerosis and haemophilia. Inclusion and diversity are at the heart of our culture, allowing our people to feel heard, valued and respected. We embrace news ways of thinking, which is integral to innovation, and allows us to better understand, connect and meet the health needs of people in Australia.
Sartorius is one of the fastest growing global life science companies and a dynamic industry leader. Our ambition is to simplify medical progress from the first idea of a new medication to its production. We support our customers with innovative technologies that make the development and manufacture of innovative therapeutics faster and more efficient. So that more people have access to better medicine. Around 16,000 employees at over 60 production and sales locations worldwide are committed to this vision.
Savills offers a wide range of property services from investment sales and leasing strategy to valuation, project management, occupier services and asset management across Australia.
Servatus BioPharmaceuticals Limited are a biopharmaceutical research and production company, based on the Sunshine Coast, Queensland. Established in 2012, we research, develop and produce high-quality, innovative, medical grade biopharmaceuticals based on the latest scientific research. Servatus has two drug research platforms: Engineered proteins for the treatment of autoimmune diseases, and microbial biotherapeutics for the treatment of inflammatory conditions and bacterial infections.
We are a Australian contract development and manufacturing organisation (CDMO) specialising in the production of nucleic acid products (mRNA) that support life-enabling work. We support our customers by providing scalable manufacturing capacity and help them accelerate innovation in bringing their products from benchtop to bedside or field. Developing and deploying our state-of-the-art bioprocessing and chemical process technologies, using proprietary manufacturing approaches, employing a highly-skilled Australian workforce.
Springfield City Group develops commercial, educational, healthcare, and residential real estate projects, with a vision of making Greater Springfield a sustainable regional city and services hub by 2030. BioPark Australia is to create a place where multiple biologic industries (Therapeutics, Vaccines, Med Tech, Diagnostics will co-locate and grow. Central to the BioPark will be its provision of the complete suite of necessary components and reagents for these industries. Future-proofing is built-in with staged expansion sites available to users.
Established in 1887, Spruson & Ferguson is one of the largest intellectual property (IP) service providers in the Asia-Pacific. As a leading Asia-Pacific IP firm, we have offices in Australia, China (Beijing and Hong Kong), Indonesia, Malaysia, Philippines, Singapore and Thailand as well as direct filing capabilities in Brunei, New Zealand and Papua New Guinea. Over the years Spruson & Ferguson has established itself as a regional IP hub, offering the highest standard of service to our clients throughout the Asia-Pacific region. Spruson & Ferguson companies are members of the IPH Limited group, which includes a range of professional services firms operating under a number of brands in a range of jurisdictions.
Communities are fundamental. Whether around the corner or across the globe, they provide a foundation, a sense of place and of belonging. That's why at Stantec, we always design with community in mind. We care about the communities we serve—because they're our communities too. This allows us to assess what's needed and connect our expertise, to appreciate nuances and envision what's never been considered, to bring together diverse perspectives so we can collaborate toward a shared success.
Stokes Lawyers is built on the Stokes family legacy of business innovation. We take a mindful and commercial approach to our passion for assisting other family businesses, and private clients, to their opportunity.
Sullivan Nicolaides Pathology is one of Australia’s largest and most respected diagnostic testing laboratories, regarded for our expertise in esoteric as much as routine testing. We are a member of the Sonic Healthcare group, a global company with a reputation for excellence.
Thomson Geer is a large Australian corporate law firm, delivering services to a wide range of industry sectors and practice areas. Thomson Geer has offices in Sydney, Melbourne, Brisbane and Adelaide. By size, they are one of the 10 largest law firms in Australia.
Trade and Investment Queensland is the Queensland Government’s dedicated global business agency, helping Queensland exporters take their products to world markets and promoting Queensland as the perfect place for investment.
Initially qualified in the Medical Laboratory Sciences, Trevor has been involved in the Healthcare/Biotechnology sector for >30 years in various roles of laboratory, sales, marketing, operational and general management of both multinationals, Australian and self-owned companies.
The Translational Research Institute (TRI) is an Australian initiative focused on advancing medical research from the laboratory to the community. Combining clinical and translational research, TRI aims to enhance detection, diagnosis, and treatment methods for various health conditions, ultimately improving patient outcomes. Their work spans across different areas, including cancer, autoimmune diseases, and more, with a focus on developing innovative treatments and diagnostics that can be translated into better healthcare practices.
The Centre for Advanced Imaging (CAI) within AIBN, is at the forefront of imaging science and is the only centre of its kind in Australia. Bringing together a critical mass of researchers and state-of-the-art preclinical and clinical research infrastructure and instruments, CAI enables world-class research through collaborations with industry and academia while fostering a rich, collaborative environment for our own experts to innovate across spectroscopic and imaging technologies. The CAI’s work is fundamental to a broad range of research fields, from major diseases affecting various organ systems, such as neurodegenerative disorders, cancer, and cardiovascular disease, through to imaging economically significant agricultural animals and plant material, minerals and construction materials. Through techniques such as Magnetic Resonance Imaging (MRI), Positron Emission Tomography (PET), Nuclear Magnetic Resonance (NMR) and Electron Paramagnetic Resonance (EPR) spectroscopy, as well as the state-of-the-art isotope production and radiochemistry capability within the centre, our researchers gain unique insights into the structure and function of biomolecules through to whole organisms. CAI’s impact on translational research is maximised through collaboration with clinical research sites and other local, national, and international research institutes. This gives CAI a comprehensive ‘end-to-end’ biomedical imaging capability which allows integrated progression from the laboratory bench, all the way through to a clinical setting.
PEF's vision is to be a world leader in protein research services, technologies and training. PEF has a team of high-performing research specialists providing research capabilities and expertise on recombinant protein production.
Queensland Brain Institute (QBI), home to 250 researchers, all working to unlock the mysteries of the brain to generate new knowledge, understand learning and memory, develop new technologies to improve lives, and diagnose and treat brain disease and mental health. Support our exciting research.
The $70 million UQ Centre for Clinical Research (CCR) at the Royal Brisbane and Women's Hospital (RBWH) is focused on improving people's lives through patient-orientated research. Offer state-of-the-art facilities and bring together leading health professionals, clinicians and scientists from around the globe.
The University of Queensland is one of Australia’s leading research and teaching institutions. We strive for excellence through the creation, preservation, transfer and application of knowledge. For more than a century, we have educated and worked with outstanding people to deliver knowledge leadership for a better world.UQ is consistently ranked among the world's top 50 universities. In the 2022 Aggregate Ranking of Top Universities, UQ ranked 2nd in Australia and 42nd in the world.
A young, fresh university driven by an unwavering belief that community and culture is just as important as a world-class education, delivered by world-class educators. We may not be the biggest university, but we’re growing fast, and doing big things. Like ground-breaking research, championing sustainability, producing gold-winning athletes and award-winning alumni. Our first campus, on the Sun
The University of Southern Queensland (USQ) is a young, dynamic university. USQ has campuses in the regional centres of Toowoomba, Springfield and Ipswich. USQ is internationally recognised for delivering practical, world-class research that delivers high-impact solutions.
UniQuest is Australia’s leading commercialisation entity, specialising in commercialising the intellectual property of The University of Queensland, a global top 50 university. Uniquest benchmarks in the top tier of technology transfer worldwide.
USC Clinical Trials, in collaboration with healthcare professionals in the Sunshine Coast and Moreton Bay, offers expert services for all phases of drug and device clinical trials. They have a wide range of therapeutic areas in their expanding portfolio. The team comprises experienced Principal and Sub-Investigators who are matched to each study based on their expertise. With over 40 completed and ongoing studies across phases I to IV, USC Clinical Trials has the necessary experience to support your research.
Urmi Quality Management Consulting (UQMC) help life science organizations establish compliant and phase-appropriate quality systems that adapt to the changing needs of the business. Combining knowledge and experience from both the Pharmaceutical and ISO 9001 Quality Management System, UQMC consultants assist life science start-ups, CDMOs, commercial manufacturers and supporting industries in adopting quality system elements that enable leaner, compliant and robust operations.
VFV is a fluid technology company providing fluid handling solutions in life sciences and design.
Vast Bioscience is a privately owned biotechnology company established to exploit a proprietary technology platform called VAST (Versatile Assembly on Stable Templates). Vast offers the pharmaceutical industry a unique opportunity to develop innovative drugs with superior potency, target selectivity and safety.
Vaxxas is commercialising novel technology that dramatically enhances the performance of existing next-generational vaccines. Their delivery platform enables robust immune system activation by targeting vaccine components to the abundant immunological cells immediately below the skin’s surface. Vaxxas’ proprietary Nanopatch™ technology aims to provide an optimised, differentiated needle-free vaccine delivery solution that safely and cost effectively amplifies vaccine efficacy.
Led by Director and Founder Dr. Patrick Silvey a specialist in Innovation Project design and scoping, VenturePro supports companies, government agencies, not-for-profits, and research organisations to become investment-ready. Dr. Silvey channels the talent and passion of VenturePro’s clients to turn discoveries and ideas into market-ready solutions or evidence-based policies for a better world. Over 18 years VenturePro has helped secure over $2.05 billion in funding for both short and long-term innovation projects and high-growth ventures.
WearOptimo is an Australian Healthtech company at the forefront of wearables and precision medicine. Our unique and patented Microwearable platform is designed to access and interpret key health signals continuously, remotely, and in real-time, while being unobtrusive and pain-free to the user.
Established in 1994 by a group of dedicated doctors, Wesley Research Institute is Queensland’s second-oldest medical research institute. Wesley Research Institute aims to improve patient outcomes by linking medical and health research to clinical outcomes.
West is a leading global manufacturer in the design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable medicines. We are a trusted partner to the world’s top pharmaceutical and biotechnology companies—working by their side to improve patient health.
Women in Technology (WiT) is one of Australia’s biggest communities that support women in across all fields of science and technology. As a not-for-profit organisation, we exist solely to create opportunities for our members and provide a dynamic platform to empower women from all disciplines to unlock their career potential. For more than two decades we have helped women find the inspiration and support they need to achieve their aspirations and, in doing so, we are helping our community take full advantage of the outstanding talent, energy and capacity they bring to our emerging digital economy.